Advertisement

Search Results

Advertisement



Your search for Chung-Han Lee, MD, PhD,Chung-Han Lee, MD, PhD matches 3 pages

Showing 1 - 3


kidney cancer
immunotherapy

Cabozantinib Plus Nivolumab in Advanced Non–Clear Cell Renal Cell Carcinoma

In a single-institution phase II study reported in the Journal of Clinical Oncology, Chung-Han Lee, MD, PhD, and colleagues found that the combination of cabozantinib and nivolumab was active in patients with advanced non–clear cell renal cell carcinoma (RCC) variants, particularly those with...

kidney cancer

Evolving Landscape of First-Line Therapy for Metastatic Renal Cell Carcinoma

In the past 3 years, we have seen a dramatic shift in the treatment paradigm for first-line therapy for metastatic clear cell renal cell carcinoma. Multiple phase III clinical trials have demonstrated improved efficacy with combinations compared with sunitinib, leading to the regulatory approval of ...

prostate cancer
breast cancer
bladder cancer
pancreatic cancer
kidney cancer
thyroid cancer
gynecologic cancers
immunotherapy

ESMO Congress 2019: Quick Takes From Key Clinical Trials

The ESMO Congress continues to grow as a pivotal platform for research in clinical oncology. At the ESMO Congress 2019, important findings were showcased in more than 2,200 studies, including 93 late-breaking abstracts. The ASCO Post summarized much of that news in separate articles over several...

Advertisement

Advertisement




Advertisement